Conference Proceedings

Efficacy and Safety of a Potent and Highly Selective Oral Tyrosine Kinase 2 Inhibitor, BMS-986165, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Placebo-Controlled Trial

Kim A Papp, Kenneth B Gordon, Diamant Thaci, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab G Girgis, Sudeep Kundu, Subhashis Banerjee

ARTHRITIS & RHEUMATOLOGY | WILEY | Published : 2018